173 related articles for article (PubMed ID: 33869742)
1. Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus.
Hill C; Grundy M; Bau L; Wallington S; Balkaran J; Ramos V; Fisher K; Seymour L; Coussios C; Carlisle R
Mol Ther Oncolytics; 2021 Jun; 21():47-61. PubMed ID: 33869742
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
[TBL] [Abstract][Full Text] [Related]
3. A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer.
Marelli G; Chard Dunmall LS; Yuan M; Di Gioia C; Miao J; Cheng Z; Zhang Z; Liu P; Ahmed J; Gangeswaran R; Lemoine N; Wang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33500259
[TBL] [Abstract][Full Text] [Related]
4. Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic Function.
Nakatake M; Kurosaki H; Kuwano N; Horita K; Ito M; Kono H; Okamura T; Hasegawa K; Yasutomi Y; Nakamura T
Mol Ther Oncolytics; 2019 Sep; 14():159-171. PubMed ID: 31236440
[TBL] [Abstract][Full Text] [Related]
5. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade.
Zuo S; Wei M; Xu T; Kong L; He B; Wang S; Wang S; Wu J; Dong J; Wei J
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949694
[TBL] [Abstract][Full Text] [Related]
6. Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus.
Ferguson MS; Chard Dunmall LS; Gangeswaran R; Marelli G; Tysome JR; Burns E; Whitehead MA; Aksoy E; Alusi G; Hiley C; Ahmed J; Vanhaesebroeck B; Lemoine NR; Wang Y
Mol Ther; 2020 May; 28(5):1263-1275. PubMed ID: 32145202
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing.
Inoue T; Byrne T; Inoue M; Tait ME; Wall P; Wang A; Dermyer MR; Laklai H; Binder JJ; Lees C; Hollingsworth R; Maruri-Avidal L; Kirn DH; McDonald DM
Mol Cancer Ther; 2021 Aug; 20(8):1481-1494. PubMed ID: 34045231
[TBL] [Abstract][Full Text] [Related]
8. First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.
Zeh HJ; Downs-Canner S; McCart JA; Guo ZS; Rao UN; Ramalingam L; Thorne SH; Jones HL; Kalinski P; Wieckowski E; O'Malley ME; Daneshmand M; Hu K; Bell JC; Hwang TH; Moon A; Breitbach CJ; Kirn DH; Bartlett DL
Mol Ther; 2015 Jan; 23(1):202-14. PubMed ID: 25292189
[TBL] [Abstract][Full Text] [Related]
9. Engineering Oncolytic Vaccinia Virus to redirect Macrophages to Tumor Cells.
Cao F; Nguyen P; Hong B; DeRenzo C; Rainusso NC; Rodriguez Cruz T; Wu MF; Liu H; Song XT; Suzuki M; Wang LL; Yustein JT; Gottschalk S
Adv Cell Gene Ther; 2021 Apr; 4(2):. PubMed ID: 33829146
[TBL] [Abstract][Full Text] [Related]
10. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
Kochneva G; Sivolobova G; Tkacheva A; Grazhdantseva A; Troitskaya O; Nushtaeva A; Tkachenko A; Kuligina E; Richter V; Koval O
Oncotarget; 2016 Nov; 7(45):74171-74188. PubMed ID: 27708236
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide.
McCart JA; Mehta N; Scollard D; Reilly RM; Carrasquillo JA; Tang N; Deng H; Miller M; Xu H; Libutti SK; Alexander HR; Bartlett DL
Mol Ther; 2004 Sep; 10(3):553-61. PubMed ID: 15336655
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy.
Shakiba Y; Vorobyev PO; Mahmoud M; Hamad A; Kochetkov DV; Yusubalieva GM; Baklaushev VP; Chumakov PM; Lipatova AV
Biochemistry (Mosc); 2023 Jun; 88(6):823-841. PubMed ID: 37748878
[TBL] [Abstract][Full Text] [Related]
13. Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity.
Hirvinen M; Capasso C; Guse K; Garofalo M; Vitale A; Ahonen M; Kuryk L; Vähä-Koskela M; Hemminki A; Fortino V; Greco D; Cerullo V
Mol Ther Oncolytics; 2016; 3():16002. PubMed ID: 27626058
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors.
Wei M; Zuo S; Chen Z; Qian P; Zhang Y; Kong L; Gao H; Wei J; Dong J
Front Immunol; 2022; 13():1017574. PubMed ID: 36451817
[TBL] [Abstract][Full Text] [Related]
15. Single-particle characterization of oncolytic vaccinia virus by flow virometry.
Tang VA; Renner TM; Varette O; Le Boeuf F; Wang J; Diallo JS; Bell JC; Langlois MA
Vaccine; 2016 Sep; 34(42):5082-5089. PubMed ID: 27614781
[TBL] [Abstract][Full Text] [Related]
16. Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development.
Ho TY; Mealiea D; Okamoto L; Stojdl DF; McCart JA
Mol Ther Oncolytics; 2021 Sep; 22():85-97. PubMed ID: 34514091
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Oncolytic Vaccinia Viruses Expressing Human β-Defensin 2 Enhance Anti-tumor Immunity.
Sun T; Luo Y; Wang M; Xie T; Yan H
Mol Ther Oncolytics; 2019 Jun; 13():49-57. PubMed ID: 31011627
[TBL] [Abstract][Full Text] [Related]
18. Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies.
Lee N; Jeon YH; Yoo J; Shin SK; Lee S; Park MJ; Jung BJ; Hong YK; Lee DS; Oh K
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36717184
[TBL] [Abstract][Full Text] [Related]
19. [Oncolytic vaccinia virus expressing CD40L (CD40L-VV) inhibits colorectal cancer cell growth and enhances anti-tumor activity of T cells in tumor-bearing mice].
Liu D; Ma J; Ding B; Zhou H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jul; 37(7):602-607. PubMed ID: 34140071
[TBL] [Abstract][Full Text] [Related]
20. Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
Carlisle R; Choi J; Bazan-Peregrino M; Laga R; Subr V; Kostka L; Ulbrich K; Coussios CC; Seymour LW
J Natl Cancer Inst; 2013 Nov; 105(22):1701-10. PubMed ID: 24168971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
